CompletedNot Applicable

Prospective Evaluation of Neurocognition in Patients Undergoing Transcatheter Aortic Valve Replacement

United States81 participantsStarted 2022-01-17

Plain-language summary

This trail is for patients with mild cognitive impairment (MCI) who are receiving a transcatheter aortic valve replacement (TAVR). We will assess changes in neurocognition following TAVR with the 5 minute Montreal Cognitive Assessment (mini MoCA) when comparing pre procedure with post procedure assessments.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18 years or older
✓. Undergoing a TAVR procedure
✓. Possible MCI as determined by procedures already used in the TAVR clinics, including 1 of the 4:
✓. MMSE \< 27
✓. History of MCI, dementia, or stroke (CVA or TIA)
✓. History of prescription treatment for MCI
✓. Discretion of the investigator, physician, or clinic staff
✓. Scores 25 or less on the mini MoCA exam

What they're measuring

Neurocognition measured by Mini MoCA at 30 days post TAVR

Timeframe: 30 days post TAVR

Trial details

NCT IDNCT05614986

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-10-02

View on ClinicalTrials.gov More Mild Cognitive Impairment trials